TCL Archive Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director January 6, 1989
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014